“Financial and economic activity indicates that the Enterprise has successfully completed its plans,” said Yu.A. Bozhkov, the chief accountant of the FSUE Moscow Endocrine Plant, “for main directive indicator of its work - the volume of gross sales revenue, the implementation amounted to 1314 million rubles, the plan is exceeded".
Net profit in the amount of 59 million roubles was received, from which the major part will be used as a source of financing of capital investments in 2017, 25% of the net profit will be transferred to federal budget revenue. According to the results of the half-year period the Enterprise put into operation fixed assets used in production activities in the amount of 45 million roubles, the net assets for the half-year period increased by 69 million roubles and reached 2157 million roubles.
The Enterprise has a high level of financial stability, provides liquidity for all current and subsequent obligations, follows the path of innovative development, improvement of the quality and competitiveness of products, and masters new areas of activity.
Comment type is not specified in the component properties.